BLLN (BillionToOne) Research & Development: $53.6 Mil (TTM As of Mar. 2026)


BLLN BillionToOne Inc BLLN
13 GF Score
Price $122.33
! 5 Warning Signs
View Full Analysis

What is BillionToOne Research & Development?

BillionToOne BLLN +2.04% 13 Research & Development is $53.6 Mil as of Mar. 2026. GuruFocus rates BLLN with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BillionToOne's Research & Development for the three months ended in Mar. 2026 was $14.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $53.6 Mil.

BillionToOne  (NAS:BLLN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BillionToOne Research & Development Related Terms

BillionToOne Research & Development Historical Data

* Premium members only.

The historical data trend for BillionToOne's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BillionToOne Research & Development Chart

BillionToOne Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
22.41 36.60 49.38

BillionToOne Quarterly Data
Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial 10.43 11.75 12.95 14.25 14.69
BLLN
13GF Score
BillionToOne Inc BLLN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BillionToOne Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $53.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $53.6 Mil mean?
BillionToOne (BLLN) has a Research & Development of $53.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on BillionToOne and its competitors.
Is BillionToOne's Research & Development too high?
BillionToOne's current Research & Development is $53.6 Mil. Overall, BillionToOne has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does BillionToOne's Research & Development compare to SHC and VCYT?
BillionToOne's Research & Development of $53.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BillionToOne and its competitors. BillionToOne's current Research & Development is $53.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BillionToOne stock overvalued right now?
BillionToOne (BLLN) has a current Research & Development of $53.6 Mil. The current Research & Development is $53.6 Mil. BillionToOne's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BillionToOne (BLLN), the current Research & Development is $53.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BillionToOne Business Description

Address 1035 O’Brien Drive, Menlo Park, CA, USA, 94025
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
13GF Score

Get the complete analysis for BLLN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$122.33
Price